Group One Trading’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,006
Closed -$263K 8844
2025
Q3
$257K Buy
+2,006
New +$245K ﹤0.01% 4398
2025
Q1
Sell
-7,868
Closed -$838K 8122
2024
Q4
$766K Buy
7,868
+777
+11% +$82.9K ﹤0.01% 2806
2024
Q3
$816K Buy
7,091
+500
+8% +$56.7K ﹤0.01% 2468
2024
Q2
$702K Buy
+6,591
New +$662K ﹤0.01% 2284
2019
Q3
Sell
-20,494
Closed -$1.84M 5421
2019
Q2
$1.87M Buy
20,494
+11,753
+134% +$995K 0.02% 1127
2019
Q1
$753K Buy
8,741
+7,555
+637% +$607K 0.01% 1617
2018
Q4
$91K Buy
+1,186
New +$92.3K ﹤0.01% 3225
2018
Q3
Sell
-65
Closed -$4.8K 5486
2018
Q2
$4K Buy
+65
New +$4.49K ﹤0.01% 4852
2017
Q4
Sell
-3,717
Closed -$280K 5099
2017
Q3
$286K Buy
+3,717
New +$281K ﹤0.01% 2505
2017
Q2
Sell
-1,340
Closed -$95K 4969
2017
Q1
$89K Sell
1,340
-1,713
-56% -$114K ﹤0.01% 3045
2016
Q4
$199K Sell
3,053
-188
-6% -$12.2K ﹤0.01% 2427
2016
Q3
$229K Sell
3,241
-7,730
-70% -$563K ﹤0.01% 2375
2016
Q2
$811K Buy
+10,971
New +$758K 0.01% 1381
2014
Q2
Sell
-227
Closed -$17.9K 5407
2014
Q1
$17K Sell
227
-1,495
-87% -$109K ﹤0.01% 4338
2013
Q4
$124K Sell
1,722
-5,189
-75% -$361K ﹤0.01% 2841
2013
Q3
$475K Buy
6,911
+4,335
+168% +$287K 0.01% 1647
2013
Q2
$163K Buy
+2,576
New +$168K ﹤0.01% 2362

Other funds holding NVS

Group One Trading's NVS Position: Q4 2025 in Review

Group One Trading sold out of Novartis (NVS) in Q4 2025, closing a stake of 2,006 shares — an estimated $263K sold.

Group One Trading first reported a position in NVS in Q2 2013 and held it in 17 quarters. The position peaked at $1.87M in Q2 2019. 1,510 funds tracked by Wall St. Rank hold NVS as of Q4 2025.

  • Group One Trading reported no remaining Novartis position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 2,006 Novartis shares in Q4 2025, an estimated $263K.
  • Group One Trading first reported a position in Novartis in Q2 2013 and held it in 17 quarters.
  • Group One Trading's Novartis position peaked at $1.87M in Q2 2019.
  • 1,510 funds tracked by Wall St. Rank held Novartis as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.